Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review

review OA: closed CC0 ⤵ 57 in-corpus citations
AI-generated summary by claude@2026-06+body, 2026-06-12

Continuous oral contraceptives after endometriosis surgery reduced dysmenorrhea recurrence, delayed symptom onset, and decreased endometrioma recurrence compared to cyclic use.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-07 · read from full text

This systematic review examined whether continuous versus cyclic combined oral contraceptive regimens after conservative surgery reduce symptom recurrence and improve patient compliance in women with endometriosis, using a Medline search to identify four eligible studies with at least 6 months of treatment and 12 months of follow-up. The authors’ cumulative, descriptive analysis found that postoperative continuous oral contraceptives were associated with lower dysmenorrhea recurrence, delayed return of dysmenorrhea, reduced nonspecific pelvic pain, and reduced endometrioma recurrence. The major limitation stated by the authors is that only four studies met strict inclusion criteria and the review used a purely descriptive approach rather than inferential analysis. This paper is centrally about endometriosis — it systematically compares continuous versus cyclic postoperative oral contraceptive regimens to reduce endometriosis symptom and lesion recurrence.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

PurposeRecurrence of endometriosis after conservative surgery has been observed in 40-50 % of patients within the first 5 years. A variety of regimens such as combined oral contraceptives, GnRH agonists, danazol, and progestins have been used postoperatively to reduce recurrence rates. Oral contraceptives (oCP) have been used either in a cyclic or in a continuous (no pill-free interval) fashion. The purpose of this article was to summarize the existing evidence on the efficacy and patient compliance for the use of oCP in a continuous versus cyclic fashion following conservative surgery for endometriosis.MethodsA systematic search of Medline identified four eligible studies. Studies were considered eligible, if they have evaluated oCP therapy, either in a cyclic or continuous regimen, after conservative surgery for endometriosis. Specifically, studies (1) reporting on women with endometriosis who were treated postoperatively with both continuous oCP and cyclic oCP, (2) written in English, (3) with minimum 6 months duration of medical treatment, and (4) with minimum 12 months duration of follow-up were considered eligible for our systematic review. Outcome measures of these eligible studies were tabulated and then analyzed cumulatively. A purely descriptive approach was adopted concerning all variables.ResultsPostoperative use of continuous oCP was associated with a reduction in the recurrence rate of dysmenorrhea, delay in the presentation of dysmenorrhea, reduction in nonspecific pelvic pain, and reduction in the recurrence rate for endometrioma.ConclusionsUse of oCP in a continuous fashion following conservative surgery for endometriosis is more beneficial to cyclic use.
Full text 7,752 characters · extracted from oa-doi-fallback · 5 sections · click to expand

Abstract

Purpose Recurrence of endometriosis after conservative surgery has been observed in 40–50 % of patients within the first 5 years. A variety of regimens such as combined oral contraceptives, GnRH agonists, danazol, and progestins have been used postoperatively to reduce recurrence rates. Oral contraceptives (oCP) have been used either in a cyclic or in a continuous (no pill-free interval) fashion. The purpose of this article was to summarize the existing evidence on the efficacy and patient compliance for the use of oCP in a continuous versus cyclic fashion following conservative surgery for endometriosis.

Methods

A systematic search of Medline identified four eligible studies. Studies were considered eligible, if they have evaluated oCP therapy, either in a cyclic or continuous regimen, after conservative surgery for endometriosis. Specifically, studies (1) reporting on women with endometriosis who were treated postoperatively with both continuous oCP and cyclic oCP, (2) written in English, (3) with minimum 6 months duration of medical treatment, and (4) with minimum 12 months duration of follow-up were considered eligible for our systematic review. Outcome measures of these eligible studies were tabulated and then analyzed cumulatively. A purely descriptive approach was adopted concerning all variables.

Results

Postoperative use of continuous oCP was associated with a reduction in the recurrence rate of dysmenorrhea, delay in the presentation of dysmenorrhea, reduction in nonspecific pelvic pain, and reduction in the recurrence rate for endometrioma.

Conclusions

Use of oCP in a continuous fashion following conservative surgery for endometriosis is more beneficial to cyclic use. Similar content being viewed by others

References

Eskenazi B, Warner ML (1997) Epidemiology of endometriosis. Obstet Gynecol Clin N Am 24:235–258 Levy AR, Osenenko KM, Lozano-Ortega G, Sambrook R, Jeddi M, Belisle S et al (2011) Economic burden of surgically confirmed endometriosis in Canada. J Obstet Gynaecol Can 33:830–837 Simoens S, Dunselman G, Dirksen C, Hummelshoj L, Bokor A, Brandes I et al (2012) The burden of endometriosis: costs and quality of life of women with endometriosis and treated in referral centres. Hum Reprod 27:1292–1299 Sampson J (1927) Peritoneal endometriosis due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol 14:422–469 Giudice LC (2010) Clinical practice. Endometriosis. N Engl J Med 362:2389–2398 Abbott J, Hawe J, Hunter D, Holmes M, Finn P, Garry R (2004) Laparoscopic excision of endometriosis: a randomized, placebo-controlled trial. Fertil Steril 82:878–884 Marcoux S, Maheux R, Berube S (1997) Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis. N Engl J Med 337:217–222 Vercellini P, Somigliana E, Vigano P, Abbiati A, Daguati R, Crosignani PG (2008) Endometriosis: current and future medical therapies. Best Pract Res Clin Obstet Gynaecol 22:275–306 Davis L, Kennedy SS, Moore J, Prentice A (2007) Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 3:CD001019 Seracchioli R, Mabrouk M, Manuzzi L, Vicenzi C, Frasca C, Elmakky A et al (2009) Post-operative use of oral contraceptive pills for prevention of anatomical relapse or symptom-recurrence after conservative surgery for endometriosis. Hum Reprod 24:2729–2735 Takamura M, Koga K, Osuga Y, Takemura Y, Hamasaki K, Hirota Y et al (2009) Post-operative oral contraceptive use reduces the risk of ovarian endometrioma recurrence after laparoscopic excision. Hum Reprod 24:3042–3048 Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP et al (2009) The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol 62:e1–e34 Seracchioli R, Mabrouk M, Frasca C, Manuzzi L, Montanari G, Keramyda A et al (2010) Long-term cyclic and continuous oral contraceptive therapy and endometrioma recurrence: a randomized controlled trial. Fertil Steril 93:52–56 Seracchioli R, Mabrouk M, Frasca C, Manuzzi L, Savelli L, Venturoli S (2010) Long-term oral contraceptive pills and postoperative pain management after laparoscopic excision of ovarian endometrioma: a randomized controlled trial. Fertil Steril 94:464–471 Vercellini P, Frontino G, De Giorgi O, Pietropaolo G, Pasin R, Crosignani PG (2003) Continuous use of an oral contraceptive for endometriosis-associated recurrent dysmenorrhea that does not respond to a cyclic pill regimen. Fertil Steril 80:560–563 Vlahos N, Vlachos A, Triantafyllidou O, Vitoratos N, Creatsas G (2013) Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective cohort study. Fertil Steril 100:1337–1342 Clark HD, Wells GA, Huet C, McAlister FA, Salmi LR, Fergusson D et al (1999) Assessing the quality of randomized trials: reliability of the Jadad scale. Control Clin Trials 20:448–452 Chapron C, Vercellini P, Barakat H, Vieira M, Dubuisson JB (2002) Management of ovarian endometriomas. Hum Reprod Update 8:591–597 Marana R, Caruana P, Muzii L, Catalano GF, Mancuso S (1996) Operative laparoscopy for ovarian cysts. Excision vs. aspiration. J Reprod Med 41:435–438 Muzii L, Marana R, Caruana P, Catalano GF, Margutti F, Panici PB (2000) Postoperative administration of monophasic combined oral contraceptives after laparoscopic treatment of ovarian endometriomas: a prospective, randomized trial. Am J Obstet Gynecol 183:588–592 Kennedy S, Bergqvist A, Chapron C, D’Hooghe T, Dunselman G, Greb R et al (2005) ESHRE guideline for the diagnosis and treatment of endometriosis. Hum Reprod 20:2698–2704 Jeng CJ, Chuang L, Shen J (2014) A comparison of progestogens or oral contraceptives and gonadotropin-releasing hormone agonists for the treatment of endometriosis: a systematic review. Expert Opin Pharmacother 15:767–773 Morotti M, Sozzi F, Remorgida V, Venturini PL, Ferrero S (2014) Dienogest in women with persistent endometriosis-related pelvic pain during norethisterone acetate treatment. Eur J Obstet Gynecol Reprod Biol 183:188–192 Busacca M (2006) Pain and endometriosis: an overview. J Minim Invasive Gynecol 13:573–575 Jain S, Dalton ME (1999) Chocolate cysts from ovarian follicles. Fertil Steril 72:852–856 Rodgers AK, Falcone T (2008) Treatment strategies for endometriosis. Expert Opin Pharmacother 9:243–255 Meresman GF, Auge L, Baranao RI, Lombardi E, Tesone M, Sueldo C (2002) Oral contraceptives suppress cell proliferation and enhance apoptosis of eutopic endometrial tissue from patients with endometriosis. Fertil Steril 77:1141–1147 Sesti F, Pietropolli A, Capozzolo T, Broccoli P, Pierangeli S, Bollea MR et al (2007) Hormonal suppression treatment or dietary therapy versus placebo in the control of painful symptoms after conservative surgery for endometriosis stage III–IV. A randomized comparative trial. Fertil Steril 88:1541–1547 Evans S, Moalem-Taylor G, Tracey DJ (2007) Pain and endometriosis. Pain 132(Suppl 1):S22–S25 Conflict of interest We declare that we have no conflict of interest. Author information Authors and Affiliations Corresponding author Electronic supplementary material Below is the link to the electronic supplementary material. Rights and permissions About this article Cite this article Zorbas, K.A., Economopoulos, K.P. & Vlahos, N.F. Continuous versus cyclic oral contraceptives for the treatment of endometriosis: a systematic review. Arch Gynecol Obstet 292, 37–43 (2015). https://doi.org/10.1007/s00404-015-3641-1 Received: Accepted: Published: Issue date: DOI: https://doi.org/10.1007/s00404-015-3641-1

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-doi-fallback

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

dysmenorrheaendometriosischronic_pelvic_pain

MeSH descriptors

Contraceptives, Oral Contraceptives, Oral, Combined Endometriosis Contraceptives, Oral Contraceptives, Oral Contraceptives, Oral, Combined Contraceptives, Oral, Combined Dysmenorrhea Dysmenorrhea Dysmenorrhea Endometriosis Endometriosis Female Humans Pelvic Pain Pelvic Pain Pelvic Pain Postoperative Period Recurrence

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (30)

Cited by (50)

Source provenance

europepmc
last seen: 2026-07-28T06:14:09.330459+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:18:04.362919+00:00
License: CC0 · commercial use OK